Close X
Thursday, November 28, 2024
ADVT 
International

Indian accused of abusing domestic help acquitted in Singapore

Darpan News Desk IANS, 20 Jan, 2023 11:56 AM
  • Indian accused of abusing domestic help acquitted in Singapore

Singapore, Jan 20 (IANS) An Indian woman accused of abusing her Indonesian domestic help and committing forgery has been given a discharge, amounting to an acquittal on all of her charges in Singapore.

This means that Ketaki Rai, 36, an Indian national and Singapore permanent resident, cannot be charged again with the same offences, The Straits Times reported.

District Judge Ronald Gwee gave the decision on Thursday after the domestic help, Susi Rimasari, left Singapore before the start of the trial.

Noting that Susi was an unwilling witness, Judge Gwee said the situation had put the accused people at a disadvantage.

The accused, Gwee said, should be entitled to have the accuser come forward in court to be open to cross-examination.

Defence lawyer Amarjit Singh Sidhu told the court that Ketaki employed Susi on January 19, 2011, to take care of her two sons and perform household chores.

Ketaki, who was accused of slapping Susi once in 2015 and another time in 2016, had earlier faced two counts each of assault and forgery.

According to The Straits Times, Ketaki had submitted a forged three-page document to Ministry of Manpower in 2016, comprising monthly salary acknowledgements for June 2015 to May 2016, purportedly signed off by Susi.

She was also accused of working together with two other Indians -- Varsha Ray and Ahjay Rai Lalhar -- by allegedly making a false one-page apology letter, purportedly signed by Susi between January 1 and September 12, 2017.

Ray and Lalhar, who were accused of forgery, were also given a discharge by the court.

As per the court documents, Ketaki is married to Lalhar's brother, while Ray is Lalhar's wife.

"Save for scolding Susi whenever she did not do a good job in caring for her sons or household chores, Ketaki denies causing any physical harm to Susi," defence lawyer Sidhu told the court.

He said that Susi left Ketaki's place at around 5 am on June 13, 2016 and sought help at a shelter, where she alleged that she had been physically abused and has not been paid her dues. "(Susi's) non-appearance in court has caused irremediable prejudice to the accused," Sidhu said in his submissions, adding that it would be unsafe to convict Ketaki, Lalhar, and Ray.

"(Susi's) evidence cannot be tested under the scrutiny of cross-examination," he added.

Ketaki could have been jailed for up to three years and fined up to $7,500 for each charge had she been convicted

MORE International ARTICLES

African scientists baffled by monkeypox cases in Europe, US

African scientists baffled by monkeypox cases in Europe, US
Cases of the smallpox-related disease have previously been seen only among people with links to central and West Africa. But in the past week, Britain, Spain, Portugal, Italy, U.S., Sweden and Canada all reported infections, mostly in young men who hadn’t previously traveled to Africa. 

African scientists baffled by monkeypox cases in Europe, US

One person killed in shooting in Oakland

One person killed in shooting in Oakland
Police found the victim off the side of a road with apparent gunshot wounds. The man died from his injuries at the scene and his identity is being withheld until his next of kin is notified, the police said.

One person killed in shooting in Oakland

WHO calls on Pfizer to make its COVID pill more available

WHO calls on Pfizer to make its COVID pill more available
WHO Director-General Tedros Adhanom Ghebreyesus said during a news briefing that Pfizer's treatment was still too expensive. He noted that most countries in Latin America had no access to Pfizer’s drug, Paxlovid , which has been shown to cut the risk of COVID-19 hospitalization or death by up to 90%.    

WHO calls on Pfizer to make its COVID pill more available

Rare cases of COVID returning pose questions for Pfizer pill

Rare cases of COVID returning pose questions for Pfizer pill
Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disease. The U.S. government has spent more than $10 billion to purchase enough pills to treat 20 million people.    

Rare cases of COVID returning pose questions for Pfizer pill

CDC probing 109 liver illnesses in kids, including 5 deaths

CDC probing 109 liver illnesses in kids, including 5 deaths
About two dozen states reported suspected cases after the Centers for Disease Control and Prevention put out a call for doctors to be on the lookout for surprising cases of hepatitis. The cases date back to late October in children under 10. So far, only nine cases in Alabama have been confirmed.    

CDC probing 109 liver illnesses in kids, including 5 deaths

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

FDA restricts J&J's COVID-19 vaccine due to blood clot risk
FDA officials said in a statement that they decided to restrict J&J's vaccine after taking another look at data on the risk of life-threatening blood clots within two week of vaccination.

FDA restricts J&J's COVID-19 vaccine due to blood clot risk